Sodium butyrate blocks interferon-gamma (IFN-γ)-induced biosynthesis of MHC class III gene products (complement C4 and factor B) in human fetal intestinal epithelial cells

Clinical and Experimental Immunology

Volumn 118, Issue 1, 1999, Pages 16-22

  Kitamura, K ^a   Andoh, Akira ^a   Inoue, T ^a   Amakata, Y ^a   Hodohara, K ^a   Fujiyama, Y ^a   Bamba, T ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

Author keywords

Short chain fatty acid; Stabilization; Stat1 ; Transcription

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BUTYRIC ACID; COMPLEMENT COMPONENT C4; GAMMA INTERFERON; GENE PRODUCT; MAJOR HISTOCOMPATIBILITY ANTIGEN; SHORT CHAIN FATTY ACID;

ARTICLE; COMPLEMENT ACTIVATION; COMPLEX FORMATION; COUNTERCURRENT SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM; MAJOR HISTOCOMPATIBILITY COMPLEX; MEDIATOR RELEASE; PRIORITY JOURNAL; RECEPTOR BLOCKING; TRANSCRIPTION REGULATION;

BLOTTING, NORTHERN; BUTYRATES; CELL LINE; COMPLEMENT C4; COMPLEMENT FACTOR B; CULTURE MEDIA, CONDITIONED; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOBLOTTING; INTERFERON TYPE II; INTESTINAL MUCOSA; PHOSPHORYLATION; RNA, MESSENGER; STAT1 TRANSCRIPTION FACTOR; TIME FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

EID: 0032869690     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.01004.x     Document Type: Article

References (34)

1. 1 Morgan BP. The complement system. In: Morgan BP, ed. Complement: clinical aspects and relevance to disease. London: Academic Press, 1991:1-35.
2. 2 Sackstein R, Colten HR. Molecular regulation of MHC class III (C4 and factor B) gene expression in mouse peritoneal macrophages. J Immunol 1984; 133:1618-26.
3. 3 Cummings JH. Short chain fully acids in the human colon. Gut 1981; 22:763-79.
4. 4 Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut 1980; 21:793-8.
5. 5 Scheppach W, Bortram P, Richter F et al. Effect of short-chain fatty acids on the human colonic mucosa in vitro. J Parent Enter Nutr 1992; 16:43-48.
6. 6 McBain JA, Eastman A, Nobel CS, Muller GC. Apoptotic death in adenocarcinoma cell lines induced by butyrate and other histone deacerylase inhibitors. Biochem Pharmacol 1997; 53:1357-68.
7. 7 Breuer RI, Buto SK, Christ ML et al. Rectal irrigation with short chain fatly acids for distal ulcerative colitis. Dig Dis Sci 1991; 36:185-7.
8. 8 Scheppach W, Sommer H, Kirchner T et al. Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 1992; 103:51-6.
9. 9 Steihart AH, Brzezinski A, Baker JP. Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas. Am J Gastroenterol 1994; 89:179-83.
10. 10 Henle G, Deinhardt F. The establishment of strains of human cells in tissue culture. J Immunol 1957; 79:54-59.
11. 11 Andoh A, Fujiyama Y, Bamba T, Hosoda S. Differential cytokine regulation of complement C3, C4, and factor B synthesis in human intestinal epithelial cell line, Caco-2. J Immunol 1993; 151:4239-47.
12. 12 Andoh A, Fujiyama Y, Sumiyoshi K, Hodohara K, Okabe H, Ochi Y, Bamba T, Brown WR. Modulation of complement C3, C4, and factor B production in human intestinal epithelial cells: differential effects of TNF-α, IFN-γ, and IL-4. Pathophysiology 1995; 2:251-9.
13. 13 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-9.
14. 14 Dignam JP, Lebovitz RM, Roeder RG. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acids Res 1983; 11:1475-89.
15. 15 Cohen HR, Strunk RC. Synthesis of complement components in liver and at extrahepatic sites. In: Whaley K, Loos M, Weiler JM, eds. Complement in health and disease. Dordrecht: Kluwer Academic Publishers, 1993:127-58.
16. 16 Seelen MAJ, Brooimans RA, Van Der Woude FJ, Es LA, Daha MR. IFN-γ mediates stimulation of complement C4 biosynthesis in human proximal tubular epithelial cells. Kidney Int 1993; 44:50-57.
17. 17 Sumiyoshi K, Andoh A, Fujiyama Y, Sakumoto H, Bamba T. Biosynthesis and secretion of MHC class III gene products (complement C4 and factor B) in the exocrine pancreas. J Gastroenterol 1997; 32:367-73.
18. 18 Kulies J, Circolo A, Strunk RC, Colten HR. Regulation of synthesis of complement protein C4 in human fibroblasts: cell-and gene-specific effects of cytokines and lipopolysaccharide. Immunology 1994; 82:509-15.
19. 19 Kulies J, Colten HR, Perlmutter DH. Counterregulatory effects of interferon-γ and endotoxin on expression of the human C4 gene. J Clin Invest 1990; 85:943-9.
20. 20 Shuai K, Schinder C, Prezioso VR, Damell JE Jr. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91-kD DNA binding protein. Science 1992: 258:1808-12.
21. 21 Naik SM, Shibagaki N, Li LJ, Quinlan KL, Paxton LL, Caughmann SW. Interferon γ-dependent induction of human intercellular adhesion molecule-1 gene expression involves activation of a distinct STAT protein complex. J Biol Chem 1997; 272:1283-90.
22. 22 Zhang JJ, Vinkemeier U, Gu W, Chakravarti D, Horvath CM, Damell JE. Two contact regions between Stat 1 and CBP/p300 in interferon γ signaling. Proc Natl Acad Sci USA 1996; 93:15092-6.
23. 23 Ahrenstedt O, Knutson L, Nilsson B, Nilsson-Ekdahl K, Odlind B, Hallgrem R. Enhanced local production of complement components in the small intestines of patients with Crohn's disease. N Engl J Med 1990; 322:1345-9.
24. 24 Andoh A, Fujiyama Y, Sakumoto H, Uchihara H, Kimura T, Koyama S, Bamba T. Detection of complement C3 and factor B gene expression in normal colorectal mucosa, adenomas and carcinomas. Clin Exp Immunol 1998; 111:477-83.
25. 25 Molmenti EP, Ziambaras T, Perlmutter DH. Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem 1993; 268:14116-24.
26. 26 Andoh A, Fujiyama Y, Sumiyoshi K, Sakumoto H, Bamba T. Interleukin-4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells, Gastroenterology 1996; 111:911-8.
27. 27 Andoh A, Fujiyama Y, Sumiyoshi K, Sakumoto H, Okabe H, Bamba T. Tumor necrosis factor-α up-regulates decay-accelerating factor gene expression in human intestinal epithelial cells. Immunology 1997; 90:358-63.
28. 28 Farrar MA, Schreiber RD. The molecular biology of interferon-γ and its receptor. Annu Rev Immunol 1993; 11:571-611.
29. 29 Kontakou M, Sturgess RP, Przemioslo RT, Limb GA, Nelufer JM, Ciclitira PJ. Detection of interferon gamma mRNA in the mucosa of patients with coeliac disease by in situ hybridization. Gut 1994; 35:1037-41.
30. 30 Al-Dawoud A, Nakshabendi I, Foulis A, Mowat AM. Immunohistochemical analysis of mucosal gamma-interferon production in coeliac disease. Gut 1992; 33:1482-6.
31. 31 Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101:428-35.
32. 32 Lappin DF, Birnie GD, Whaley K. Interferon-mediated transcriptional modulation of complement gene expression in human monocytes. Eur J Biochem 1990; 194:177-84.
33. 33 Lappin DF, Guc D, Hill A, McShane T, Whaley K. Effect of interferon-γ on complement gene expression in different cell types. Biochem J 1992; 281:437-42.
34. 34 Mitchell TJ, Naughton M, Norsworthy P, Davies KA, Walport MJ, Morley BJ. IFN-γ up-regulates expression of the complement components C3 and C4 by stabilization of mRNA. J Immunol 1996; 156:4429-34.